DCF — ST. JOSEPHS MEDICAL CENTER
Enterprise Value: $-188.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-188.3M
Enterprise Value
$-63.0M
PV of Cash Flows
$-125.3M
PV of Terminal Value
$-201.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $219.3M | $-9.9M | -4.0% | $-19.1M | $-17.4M |
| Year 2 | $225.9M | $-7.9M | -3.0% | $-17.5M | $-14.4M |
| Year 3 | $232.6M | $-5.8M | -2.0% | $-15.7M | $-11.8M |
| Year 4 | $239.6M | $-4.8M | -2.0% | $-14.9M | $-10.2M |
| Year 5 | $246.8M | $-4.3M | -2.0% | $-14.8M | $-9.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-188.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$212.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.049999999530274605
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5